Suicide warning for kids on ADHD drug Strattera

Posted Oct 3, 2013 by Jeannie Stokowski-Bisanti
In a medicines safety update this week, Australia's Therapeutic Goods Administration said that it had received 28 reports of suicidal thoughts in both teenagers and children as young as seven after taking ADHD drug Strattera.
A young girl playing on the beach
A young girl playing on the beach
Mike Baird/
After reports of two children trying to take their own lives and a nine-year-old boy taking his own life, Australia's drug regulator has warned doctors to carefully weigh up the risk of suicidal thoughts in children taking Strattera.
Strattera, known generically as atomoxetine, was approved in Australia in 2004 and added to the Pharmaceutical Benefits Scheme in 2007. Pharmaceutical company Lilly is the maker Strattera.
The country's Commonwealth Health Department figures show that approximately 6000 Australian children were on Strattera in 2011. In the United States- 351,000 children are being prescribed Stattera, 7,900 of them aged 0-5 years old.
Sixteen drug regulatory agencies have issued warnings from six countries (United States, Australia, Ireland, United Kingdom, Canada and Russia) and the European Union.